CureVac
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,245 | $893 | $14,469 | $493,902 |
Gross Profit | -968 | 18 | 12,983 | 471,971 |
EBITDA | -54,993 | -46,745 | 375,225 | |
EBIT | -59,401 | -51,322 | 370,713 | |
Net Income | -59,560 | -52,084 | -32,761 | 338,043 |
Net Change In Cash | 1,245 | 893 | 14,469 | 493,902 |
Free Cash Flow | -43,617 | -41,885 | -69,132 | 350,781 |
Cash | 392,703 | 438,331 | 481,748 | 550,862 |
Basic Shares | 225,172 | 225,150 | 224,338 | 224,313 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $535,180 | $53,758 | $67,420 | $102,990 |
Gross Profit | 429,351 | -70,608 | -116,573 | -135,205 |
EBITDA | 209,690 | -234,090 | -209,386 | -386,486 |
EBIT | 190,881 | -257,476 | -235,547 | -422,364 |
Net Income | 162,186 | -260,167 | -249,029 | -411,716 |
Net Change In Cash | 535,180 | 53,758 | 67,420 | 102,990 |
Free Cash Flow | 83,407 | -323,087 | -379,399 | -861,029 |
Cash | 481,748 | 402,452 | 495,797 | 811,464 |
Basic Shares | 225,270 | 220,833 | 189,074 | 186,012 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.15 |
2025-03-31 | -$0.15 |
2024-12-31 | -$0.14 |
